---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-022061"
form_type: "8-K"
ticker: "BTCY"
cik: "0001630113"
company_name: "BIOTRICITY INC."
filed_at: "2022-08-11T23:59:59+00:00"
generated_at: "2026-06-24T00:52:49.443740+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Two Biotricity directors resign; Chester White appointed to board

## Summary
- Patricia Kennedy resigned from board and audit/nominating committees effective Aug 5, 2022.
- Norman Betts resigned from board and audit committee effective Aug 5, 2022.
- Chester White appointed to board on Aug 11, 2022 to fill Kennedy vacancy; no committee assignments yet.
- White has experience in fund management, venture capital, and technology innovation.

## SEC filing metadata
- accession: 0001493152-22-022061
- form_type: 8-K
- ticker: BTCY
- cik: 0001630113
- company_name: BIOTRICITY INC.
- filed_at: 2022-08-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630113/000149315222022061/0001493152-22-022061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630113/000149315222022061/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-022061
- JSON: https://secwatch.observer/filing/0001493152-22-022061.json
- Plain text: https://secwatch.observer/filing/0001493152-22-022061.txt

## Key facts
- Executive change
  Patricia Kennedy resigned as Director and member of Audit Committee and Nominating and Corporate Governance Committee at BIOTRICITY INC..
  - Action: resigned
  - Role: Director and member of Audit Committee and Nominating and Corporate Governance Committee
  source text: On August 5, 2022, Patricia Kennedy as a member of the Board of Directors of Biotricity Inc. (the “Company”), a member of the Company’s Audit Committee, and a member of the Company’s Nominating and Corporate Governance Committee, resigned from the Company’s Board of Directors effective August 5, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315222022061/0001493152-22-022061-index.htm
- Executive change
  Chester White was appointed as Director at BIOTRICITY INC..
  - Action: appointed
  - Role: Director
  source text: On August 11, 2022, the Board of Directors of the Company appointed Chester White to the Board of Directors to fill the vacancy created by Patricia Kennedy’s resignation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315222022061/0001493152-22-022061-index.htm
- Executive change
  Norman Betts resigned as Director and member of Audit Committee at BIOTRICITY INC..
  - Action: resigned
  - Role: Director and member of Audit Committee
  source text: On August 5, 2022, Norman Betts as a member of the Board of Directors of Biotricity Inc. (the “Company”) and a member of the Company’s Audit Committee, resigned from the Company’s Board of Directors effective August 5, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1630113/000149315222022061/0001493152-22-022061-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.